神澤 太一
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position  
Article types Original article
Language English
Peer review Peer reviewed
Title Desensitization Regimen Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab (an Anti-CD20 Antibody), Without Eculizumab and/or Bortezomib, in 41 Highly Sensitized Kidney Transplant Recipients
Journal Formal name:Experimental and Clinical Transplantation
Abbreviation:Exp Clin Transplant
Domestic / ForeginForegin
Volume, Issue, Page 19(10),pp.1032-1040
Author and coauthor ISHIDA Hideki†*, UNAGAMI Kohei, OMOTO Kazuya, KANZAWA Taichi, TANABE Kazunari
Publication date 2021/09/08
DOI 10.6002/ect.2021.0234